Cargando…
Tocilizumab in COVID-19: some clarity amid controversy
Autores principales: | Gupta, Shruti, Leaf, David E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084409/ https://www.ncbi.nlm.nih.gov/pubmed/33933194 http://dx.doi.org/10.1016/S0140-6736(21)00712-1 |
Ejemplares similares
-
Thermal ablation for papillary thyroid microcarcinoma: Some clarity amid controversies
por: Yue, Wenwen, et al.
Publicado: (2022) -
Can tocilizumab calm the cytokine storm of COVID-19?
por: Schulert, Grant S
Publicado: (2020) -
Asthma and COVID-19: a controversial relationship
por: Dounce-Cuevas, Carlos A., et al.
Publicado: (2023) -
Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic
por: South, Andrew M., et al.
Publicado: (2020) -
Building resilient Arctic science amid the COVID-19 pandemic
por: Petrov, Andrey N., et al.
Publicado: (2020)